Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) Director Mark J. Rubash sold 1,709 shares of Intuitive Surgical stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $380.00, for a total value of $649,420.00. Following the sale, the director now owns 16,051 shares of the company's stock, valued at approximately $6,099,380. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.
Intuitive Surgical Price Performance
Shares of NASDAQ:ISRG opened at $383.05 on Tuesday. The stock's 50-day moving average is $385.29 and its 200 day moving average is $351.11. The company has a market cap of $135.87 billion, a PE ratio of 69.14, a P/E/G ratio of 4.93 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $403.76.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm had revenue of $1.89 billion for the quarter, compared to analysts' expectations of $1.87 billion. During the same period in the previous year, the firm earned $1.00 earnings per share. The business's revenue was up 11.5% compared to the same quarter last year. Analysts expect that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.
Analyst Ratings Changes
Bill Gates is all about this tiny $2 stock
From Timothy Sykes | Ad
What does Bill Gates know about this tiny company that we don’t?
From the outside, it looks like a worthless $2 stock…
>>Click here to discover why Bill Gates is all about this tiny $2 stock.
ISRG has been the subject of several research analyst reports. BTIG Research lifted their target price on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a "buy" rating in a research report on Friday, April 19th. Jefferies Financial Group lifted their price objective on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a "hold" rating in a report on Friday, April 19th. Stifel Nicolaus raised their price target on Intuitive Surgical from $420.00 to $430.00 and gave the company a "buy" rating in a research report on Monday, April 8th. Robert W. Baird dropped their price target on Intuitive Surgical from $440.00 to $436.00 and set an "outperform" rating for the company in a research note on Friday, April 19th. Finally, Mizuho increased their price objective on Intuitive Surgical from $350.00 to $390.00 and gave the company a "neutral" rating in a research report on Thursday, January 25th. Five analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus price target of $396.17.
Get Our Latest Stock Analysis on Intuitive Surgical
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the stock. OFI Invest Asset Management purchased a new stake in Intuitive Surgical in the third quarter worth about $25,000. Baystate Wealth Management LLC raised its position in shares of Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 45 shares in the last quarter. MCF Advisors LLC lifted its stake in shares of Intuitive Surgical by 108.1% in the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 40 shares during the period. Headinvest LLC bought a new stake in shares of Intuitive Surgical during the third quarter valued at approximately $28,000. Finally, Able Wealth Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth $28,000. 83.64% of the stock is currently owned by institutional investors.
Intuitive Surgical Company Profile
(
Get Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
